Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Biochemistry|October 21, 1986
Accessibility of the leading end of ribonucleic acid in transcription complexesS L Bernhard, C F MearesBiochemistry|October 7, 1986
The sigma subunit of RNA polymerase contacts the leading ends of transcripts 9-13 bases long on the lambda PR promoter but not on T7 A1S L Bernhard, C F MearesCancer Research|June 1, 1992
Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemiaD M Fishwild, S Aberle, S L Bernhard, et al.Clinical and Experimental Immunology|July 1, 1994
Characterization of the increased cytotoxicity of gelonin anti-T cell immunoconjugates compared with ricin A chain immunoconjugatesD M Fishwild, H M Wu, S F Carroll, et al.International Journal of Immunopharmacology|November 1, 1993
Efficacy of anti-CD5 F(ab')2 and Fab' immunoconjugates in human peripheral blood lymphocyte-reconstituted severe combined immunodeficient miceF R Kohn, D M Fishwild, S L Bernhard, et al.The Journal of Biological Chemistry|August 15, 1992
Activity of recombinant mitogillin and mitogillin immunoconjugatesM Better, S L Bernhard, S P Lei, et al.Bioconjugate Chemistry|May 1, 1994
Enhanced stability in vitro and in vivo of immunoconjugates prepared with 5-methyl-2-iminothiolaneS F Carroll, S L Bernhard, D A Goff, et al.The Journal of Biological Chemistry|April 1, 1994
Gelonin analogs with engineered cysteine residues form antibody immunoconjugates with unique propertiesM Better, S L Bernhard, D M Fishwild, et al.Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993
Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2M Better, S L Bernhard, S P Lei, et al.The Journal of Biological Chemistry|June 23, 1995
T cell-targeted immunofusion proteins from Escherichia coliM Better, S L Bernhard, R E Williams, et al.Pageof 2